HPA axis dysregulation and phenomenology of depression

HPA 轴失调与抑郁症的现象学

基本信息

  • 批准号:
    7243449
  • 负责人:
  • 金额:
    $ 18.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-07-01 至 2009-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The aim of this NIMH Mentored Patient-Oriented Research Career Development Award application is to support my career objective to become an independent investigator specializing in the relationship between neurobiological mechanisms and clinical features of depression. My previous training focuses on phenomenological and treatment studies in mood disorders. Studies suggest that HPA dysregulation influences the presentation of depression related to melancholic and atypical symptom dimensions. A better understanding of the mechanisms underlying these differences could lead to novel targets for the treatment of depression, and help to explain variability among neuroendocrine studies that typically included heterogeneous samples with regard to depressive subtypes. Toward this end, I have proposed a training plan that includes obtaining expertise in the neurobiology of HPA dysregnlation in depression, statistical design and analysis of studies integrating biological and clinical data, and human research ethics. The research plan includes assessing HPA activity and measures of acute stress responses in healthy volunteers and depressed patients as they relate to melancholic and atypical symptom dimensions. The hypothesis is that elevated HPA axis activity in depression is associated with hyperarousal and anorexia in melancholia, whereas low HPA activity is linked with fatigue and hyperphagia in atypical depression. Moreover, increased HPA activity and melancholic symptoms are hypothesized to correlate with greater response to the Trier Social Stress Test (TSST), whereas low HPA activity and atypical symptoms are hypothesized to correlate with a decreased stress response to the TSST. These hypotheses will be tested by collection of 24-hour urinary free cortisol, and plasma cortisol and ACTH levels in depressed patients in three separate conditions: one-hour serial collections in the morning and evening; after a neuroendocrine challenge used to assess central HPA drive (DEX/CRH test); and in response to the TSST. This study will be conducted in two highly productive research settings, the Biological Psychiatry and Bipolar and Psychotic Disorder Research Programs of the University of Cincinnati Dept. of Psychiatry. The proposed training and research plans will foster my development as an independent researcher in the areas described above, and increase our understanding of the neurobiology related to the symptom profiles associated with depressive subtypes.
描述(由申请人提供):这个NIMH指导的以患者为导向的研究职业发展奖申请的目的是支持我的职业目标,成为一名独立的研究者,专门研究神经生物学机制和抑郁症的临床特征之间的关系。我以前的训练集中在情绪障碍的现象学和治疗研究。研究表明,HPA失调影响抑郁症的表现与抑郁症和非典型症状的维度。更好地理解这些差异的机制可能会导致抑郁症治疗的新靶点,并有助于解释神经内分泌研究中的变异性,这些研究通常包括抑郁亚型的异质性样本。为此,我提出了一个培训计划,包括获得抑郁症HPA失调的神经生物学专业知识,整合生物学和临床数据的研究的统计设计和分析,以及人类研究伦理。研究计划包括评估健康志愿者和抑郁症患者的HPA活性和急性应激反应的措施,因为它们与抑郁症和非典型症状维度有关。该假说认为,抑郁症中HPA轴活性升高与抑郁症中的过度觉醒和厌食有关,而HPA轴活性降低与非典型抑郁症中的疲劳和暴食有关。此外,假设HPA活性增加和抑郁症状与对特里尔社会应激测试(TSST)的更大反应相关,而假设低HPA活性和非典型症状与对TSST的应激反应降低相关。这些假设将通过在三种不同条件下收集抑郁症患者的24小时尿游离皮质醇、血浆皮质醇和ACTH水平进行检验:在早晨和晚上连续收集1小时;用于评估中枢HPA驱动的神经内分泌激发后(DEX/CRH试验);以及对TSST的反应。本研究将在两个高生产力的研究环境中进行,即辛辛那提大学系的生物精神病学和双相情感障碍研究项目。精神病学。拟议的培训和研究计划将促进我作为上述领域的独立研究人员的发展,并增加我们对与抑郁亚型相关的症状特征相关的神经生物学的理解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ERIK Bertil NELSON其他文献

ERIK Bertil NELSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ERIK Bertil NELSON', 18)}}的其他基金

PHENOMENOLOGY OF MAJOR DEPRESSION
重度抑郁症的现象学
  • 批准号:
    7607731
  • 财政年份:
    2007
  • 资助金额:
    $ 18.23万
  • 项目类别:
PHENOMENOLOGY OF MAJOR DEPRESSION
重度抑郁症的现象学
  • 批准号:
    7374502
  • 财政年份:
    2005
  • 资助金额:
    $ 18.23万
  • 项目类别:
HPA axis dysregulation and phenomenology of depression
HPA 轴失调与抑郁症的现象学
  • 批准号:
    6915197
  • 财政年份:
    2004
  • 资助金额:
    $ 18.23万
  • 项目类别:
PHENOMENOLOGY OF MAJOR DEPRESSION
重度抑郁症的现象学
  • 批准号:
    7203749
  • 财政年份:
    2004
  • 资助金额:
    $ 18.23万
  • 项目类别:
HPA axis dysregulation and phenomenology of depression
HPA 轴失调与抑郁症的现象学
  • 批准号:
    7092544
  • 财政年份:
    2004
  • 资助金额:
    $ 18.23万
  • 项目类别:
HPA axis dysregulation and phenomenology of depression
HPA 轴失调与抑郁症的现象学
  • 批准号:
    7436338
  • 财政年份:
    2004
  • 资助金额:
    $ 18.23万
  • 项目类别:
HPA axis dysregulation and phenomenology of depression
HPA 轴失调与抑郁症的现象学
  • 批准号:
    7871118
  • 财政年份:
    2004
  • 资助金额:
    $ 18.23万
  • 项目类别:
HPA axis dysregulation and phenomenology of depression
HPA 轴失调与抑郁症的现象学
  • 批准号:
    6828444
  • 财政年份:
    2004
  • 资助金额:
    $ 18.23万
  • 项目类别:
Phenomenology of Major Depression
重度抑郁症的现象学
  • 批准号:
    7044188
  • 财政年份:
    2003
  • 资助金额:
    $ 18.23万
  • 项目类别:

相似海外基金

Relationship between Biomarkers of Oxidative Stress and Agitation Severity in Moderate-to-severe Alzheimer's Disease
中重度阿尔茨海默病氧化应激生物标志物与躁动严重程度之间的关系
  • 批准号:
    497994
  • 财政年份:
    2023
  • 资助金额:
    $ 18.23万
  • 项目类别:
Effects of dexmedetomidine on agitation in critically ill TBI patients - DEX-TBI
右美托咪定对危重 TBI 患者躁动的影响 - DEX-TBI
  • 批准号:
    488402
  • 财政年份:
    2023
  • 资助金额:
    $ 18.23万
  • 项目类别:
    Operating Grants
Co-design and evaluation of sensor-instrumented ‘smart socks’ (MPATIX) to improve management of distress and agitation for people with dementia
共同设计和评估传感器仪表“智能袜子”(MPATIX),以改善痴呆症患者的痛苦和躁动管理
  • 批准号:
    10055596
  • 财政年份:
    2023
  • 资助金额:
    $ 18.23万
  • 项目类别:
    Collaborative R&D
Identifying pre-agitation biometric signature in dementia patients: A feasibility study
识别痴呆症患者的躁动前生物识别特征:可行性研究
  • 批准号:
    486612
  • 财政年份:
    2022
  • 资助金额:
    $ 18.23万
  • 项目类别:
    Studentship Programs
Relationship between 4-Hydroxynonenal and Agitation Severity in Alzheimer’s Disease
4-羟基壬烯醛与阿尔茨海默病患者躁动严重程度之间的关系
  • 批准号:
    486589
  • 财政年份:
    2022
  • 资助金额:
    $ 18.23万
  • 项目类别:
    Studentship Programs
Agitation in Alzheimer's Disease: Identification and Prediction Using Digital Behavioral Markers and Indoor Environmental Factors
阿尔茨海默病中的躁动:使用数字行为标记和室内环境因素进行识别和预测
  • 批准号:
    10404523
  • 财政年份:
    2021
  • 资助金额:
    $ 18.23万
  • 项目类别:
Clinical Decision Support Tool to Assess Risk and Prevent Agitation Events
用于评估风险和预防躁动事件的临床决策支持工具
  • 批准号:
    10683499
  • 财政年份:
    2021
  • 资助金额:
    $ 18.23万
  • 项目类别:
Development of Memesto, a wearable repetitive message and music therapy device that senses and reduces agitation in persons with AD/ADRD.
开发 Memesto,一种可穿戴式重复信息和音乐治疗设备,可感知并减少 AD/ADRD 患者的躁动。
  • 批准号:
    10322846
  • 财政年份:
    2021
  • 资助金额:
    $ 18.23万
  • 项目类别:
Agitation in Alzheimer's Disease: Identification and Prediction Using Digital Behavioral Markers and Indoor Environmental Factors
阿尔茨海默病中的躁动:使用数字行为标记和室内环境因素进行识别和预测
  • 批准号:
    10190522
  • 财政年份:
    2021
  • 资助金额:
    $ 18.23万
  • 项目类别:
Clinical Decision Support Tool to Assess Risk and Prevent Agitation Events
用于评估风险和预防躁动事件的临床决策支持工具
  • 批准号:
    10365272
  • 财政年份:
    2021
  • 资助金额:
    $ 18.23万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了